Medicines Co. Snares HDL Drug in Potential $410M Pfizer Deal

Nov. 1, 2011

By Glen Harris

No Abstract

Read More

Kosan Cuts Staff, Adds CEO and Focuses on its Pipeline

Nov. 1, 2011

By Glen Harris

No Abstract

Read More

PDL Divestiture Continues in $170M Deal with EKR

Nov. 1, 2011

By Glen Harris

No Abstract

Read More

Phenomix Seeking $86M IPO to Push Diabetes Candidate

Nov. 1, 2011

By Glen Harris

No Abstract

Read More

Regeneron Signs Another Deal For A Potential $120M Payoff

Nov. 1, 2011

By Glen Harris

No Abstract

Read More

Arginetix, Immune Control Merge Two Corridors in Vascular Space

June 18, 2010

By Glen Harris

Alvine Brings in Another $21M to Fund Celiac Disease Studies

Sep. 16, 2009

By Glen Harris

NPS Boosts Treasury with $40M Equity Financing for Pivotal Trials

Aug. 7, 2009

By Glen Harris

Infinity Halts Tumor Trial Due to High Mortality Data

April 16, 2009

By Glen Harris

Lean Sunesis Gets Flush with $43.5M Placement

April 2, 2009

By Glen Harris